Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01090362 · ClinicalTrials.gov registry record
Global Anticoagulant Registry in the Field
A clinical trial, sponsored by Thrombosis Research Institute.
- Completed
- Registry status
- 57,250
- Enrollment target
NCT01090362 is a clinical trial that has completed, run by Thrombosis Research Institute. The registered enrollment target is 57,250 participants.
The verdict
NCT01090362 has completed, sponsored by Thrombosis Research Institute.
- COMPLETED
- Registry status
- 57,250 participants
- Enrollment target
Study Summary
The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF Registry) is a non-interventional, observational study that characterized a global population of non-valvular atrial fibrillation patients. The registry was used to document global baseline characteristics, current treatment strategies and outcome measures. Characterisation of a number of AF sub-populations was also completed. GARFIELD-AF is an independent academic research initiative sponsored by the Thrombosis Research Institute (London, UK) and supported by an unrestricted research grant from Bayer AG (Berlin, Germany).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57,250 participants |
| Start Date | 2009-12-21 |
| Est. Completion | 2020-05-18 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01090362
The ClinicalTrials.gov registry entry for NCT01090362 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 57,250 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Thrombosis Research Institute, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01090362 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01090362 about?
NCT01090362 is a clinical study titled "Global Anticoagulant Registry in the Field". The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF Registry) is a non-interventional, observational study that characterized a global population of non-valvular atrial fibrillation patients. The registry was used to document global baseline characteristics, current treat...
What is the current status of trial NCT01090362?
This trial is currently completed. The enrollment target is 57,250 participants. The study started on 2009-12-21. Estimated completion is 2020-05-18.
Who is sponsoring clinical trial NCT01090362?
This trial is sponsored by Thrombosis Research Institute, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.